By Tony Fong

NEW YORK (GenomeWeb News) – A UK firm founded three years ago is looking to shake up the BRCA testing market.

In mid-2010, NewGene, based in Newcastle upon Tyne, launched its next-generation sequencing-based BRCA1 and BRCA2 testing service for breast cancer in the UK. Initially, the test is being targeted to patients with a family history of breast cancer with a longer-term goal of developing it as a general screen for the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.